The Cigna Group (CI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,288,000 | 5,014,000 | 3,041,000 | 1,409,000 | 3,778,000 |
| Depreciation Amortization | 2,775,000 | 2,053,000 | 1,356,000 | 674,000 | 2,775,000 |
| Income taxes - deferred | 326,000 | -174,000 | -292,000 | -216,000 | -95,000 |
| Accounts payable and accrued liabilities | 4,665,000 | 980,000 | -25,000 | -1,039,000 | 9,895,000 |
| Other Working Capital | 201,000 | -3,286,000 | -3,980,000 | 92,000 | 1,192,000 |
| Other Operating Activity | -4,654,000 | -1,135,000 | -66,000 | 1,000,000 | -7,182,000 |
| Operating Cash Flow | $9,601,000 | $3,452,000 | $34,000 | $1,920,000 | $10,363,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,212,000 | -890,000 | -612,000 | -327,000 | -1,406,000 |
| Net Acquisitions | 2,387,000 | 1,749,000 | 2,346,000 | 2,346,000 | 390,000 |
| Purchase Of Investment | -7,321,000 | -6,454,000 | -2,335,000 | -1,461,000 | -2,749,000 |
| Sale Of Investment | 2,875,000 | 2,117,000 | 1,346,000 | 732,000 | 2,635,000 |
| Other Investing Activity | -1,136,000 | -509,000 | -345,000 | -93,000 | -972,000 |
| Investing Cash Flow | $-4,407,000 | $-3,987,000 | $400,000 | $1,197,000 | $-2,102,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -927,000 | -915,000 | 296,000 | -891,000 | -402,000 |
| Debt Issued | 6,457,000 | 6,460,000 | 0 | N/A | 4,462,000 |
| Debt Repayment | -6,197,000 | -3,643,000 | -1,600,000 | -700,000 | -3,000,000 |
| Common Stock Issued | 203,000 | 178,000 | 141,000 | 69,000 | 305,000 |
| Common Stock Repurchased | -3,621,000 | -2,620,000 | -2,620,000 | -1,508,000 | -7,034,000 |
| Dividend Paid | -1,611,000 | -1,215,000 | -813,000 | -412,000 | -1,567,000 |
| Other Financing Activity | -725,000 | -600,000 | -418,000 | -239,000 | -411,000 |
| Financing Cash Flow | $-6,421,000 | $-2,355,000 | $-5,014,000 | $-3,681,000 | $-7,647,000 |
| Exchange Rate Effect | 32,000 | 30,000 | 35,000 | 9,000 | -20,000 |
| Beginning Cash Position | 8,931,000 | 8,931,000 | 8,931,000 | 8,931,000 | 8,337,000 |
| End Cash Position | 7,736,000 | 6,071,000 | 4,386,000 | 8,376,000 | 8,931,000 |
| Net Cash Flow | $-1,195,000 | $-2,860,000 | $-4,545,000 | $-555,000 | $594,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,601,000 | 3,452,000 | 34,000 | 1,920,000 | 10,363,000 |
| Capital Expenditure | -1,212,000 | -890,000 | -612,000 | -327,000 | -1,406,000 |
| Free Cash Flow | 8,389,000 | 2,562,000 | -578,000 | 1,593,000 | 8,957,000 |